Inventor
CONNELLY SHEILA
US32 patents
⚠️ This page may combine multiple inventors who share the name “CONNELLY SHEILA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTHETIC BIOLOGICS INC
16 patentsUS11236319B2Feb 1, 2022
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10767171B2Sep 8, 2020
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10584326B2Mar 10, 2020
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10336995B2Jul 2, 2019
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10087433B1Oct 2, 2018
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10011824B2Jul 3, 2018
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US9783797B1Oct 10, 2017
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US9695409B2Jul 4, 2017
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US9464280B1Oct 11, 2016
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations74
US9404103B1Aug 2, 2016
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations74
US10548955B2Feb 4, 2020
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
SYNTHETIC BIOLOGICS INC3 citations73
US10046035B2Aug 14, 2018
Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGICS INC2 citations71
US9744221B2Aug 29, 2017
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGICS INC3 citations71
US10828260B2Nov 10, 2020
Beta-lactamase formulations and uses thereof
SYNTHETIC BIOLOGICS INC0 citations51
US10105322B2Oct 23, 2018
Beta-lactamase formulations and uses thereof
SYNTHETIC BIOLOGICS INC0 citations51
US10792346B2Oct 6, 2020
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGICS INC0 citations50
THERIVA BIOLOGICS INC
6 patentsUS11608494B2Mar 21, 2023
Beta-lactamases with improved properties for therapy
THERIVA BIOLOGICS INC2 citations84
US12274740B2Apr 15, 2025
Microbiome protection from oral antibiotics
THERIVA BIOLOGICS INC0 citations62
US11883474B2Jan 30, 2024
Microbiome protection from oral antibiotics
THERIVA BIOLOGICS INC0 citations62
US12178917B2Dec 31, 2024
Beta-lactamase formulations and uses thereof
THERIVA BIOLOGICS INC0 citations61
US11654184B2May 23, 2023
Alkaline phosphatase agents for treatment of radiation disorders
THERIVA BIOLOGICS INC1 citations61
US11944669B2Apr 2, 2024
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
THERIVA BIOLOGICS INC0 citations60
SYNTHETIC BIOLOGIES INC
4 patentsUS11517614B2Dec 6, 2022
Microbiome protection from oral antibiotics
SYNTHETIC BIOLOGIES INC0 citations61
US11123413B2Sep 21, 2021
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
SYNTHETIC BIOLOGIES INC0 citations61
US11596674B2Mar 7, 2023
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGIES INC0 citations59
US11338020B2May 24, 2022
Alkaline phosphatase agents for treatment of neurodevelopmental disorders
SYNTHETIC BIOLOGIES INC0 citations59